# Episode 180 - Ben Zimmer - CEO of Priovant Therapeutics

Page: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-180-ben-zimmer-ceo-of-priovant-therapeutics
Text version: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-180-ben-zimmer-ceo-of-priovant-therapeutics.md
Podcast: [The BioHub - by Avetix](https://stenobird.com/podcast/the-biohub-by-avetix-7252289)
Published: 2026-05-26T14:41:42+00:00
Episode link: https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-180---Ben-Zimmer---CEO-of-Priovant-Therapeutics-e3jn2bm
Audio file: https://anchor.fm/s/f0076084/podcast/play/120342326/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-26%2F424914274-44100-2-5c7d691a53bfc.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-180-ben-zimmer-ceo-of-priovant-therapeutics
Duration seconds: 1676

## Resource

In this episode of The BioHub Podcast , Max sits down with Ben Zimmer, CEO of Priovant Therapeutics. Ben was among the first ten employees at Roivant, helping incubate and launch multiple biotech companies before going on to found Priovant in 2021. Priovant is a clinical-stage biotech focused on developing therapies for severe autoimmune diseases — one of the most active and fast-moving areas in biotech today. In this conversation, we talk about the early days of Roivant, the inspiration behind building Priovant, why autoimmune disease has become such a major focus across the industry, and what it takes to build teams and companies in high-stakes therapeutic areas. We also discuss leadership, decision-making, and what’s next for Priovant.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-180-ben-zimmer-ceo-of-priovant-therapeutics/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-180-ben-zimmer-ceo-of-priovant-therapeutics.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.